Who is eligible for clinical trial NCT07118306?

Participants must meet protocol criteria for COPD (Chronic Obstructive Pulmonary Disease). Confirm exact inclusion and exclusion requirements with the study coordinator.

Does clinical trial NCT07118306 provide travel or cost reimbursement?

Check with the site coordinator at the participating facility for travel and lodging stipend availability, and for which routine-care costs are covered.

🏛️ Verified NIH Record • Updated 2026-06-02

COPD Exacerbation Follow Up (NCT07118306)

🟢 Recruiting Interventional Protocol 📊 Observational Clinical Research Sponsor: Viz.ai, Inc.

🩺 Plain-English Summary (8th-Grade Level)

The goal of this study is to evaluate the impact of implementing an AI-enabled clinical workflow tool (Viz COPD) on respiratory specialist follow up and clinical outcomes after an acute exacerbation.

Who can join: To join this study, participants generally need to meet the listed inclusion criteria (5 items) and avoid the listed exclusions (8 items).

Location: Advocate Lutheran General Hospital — Park Ridge, Illinois

📋 "Do I Qualify?" — 1-Minute Self Screener

Instant Checklist

Check every box below. If you can check all of them, you may meet the study's basic screening requirements (final eligibility is confirmed by the site team).

Patients aged 40 years or older at the time of arrival to the emergency department.
Patients with a clinical diagnosis of COPD who present to the emergency department for a moderate or severe COPD exacerbation.
A moderate exacerbation is defined as an acute exacerbation requiring either systemic corticosteroids (such as intramuscular, intravenous or oral) and/or antibiotics.
A severe exacerbation is defined as an acute exacerbation requiring hospitalization, or observation for \>24 hours in emergency department/urgent care facility or resulting in death.
Patients on dual (LABA/LAMA, LABA/ICS, LAMA/ICS) or triple (LABA/LAMA/ICS) long-acting bronchodilator inhalers.

Usually NOT eligible if any of the following apply:

Exclusion Criteria:
Patients on bronchodilator inhaler monotherapy.
Patients leaving against medical advice or expiring during hospitalization.
Patients with tracheostomy.
Patients with advanced cancer.
Patients who have received a lung transplant.
Discharge to hospice care.
Transfer to another hospital.

🔍 Extracted verbatim from the official NIH eligibility criteria. Always confirm with the study coordinator.

📍 All Participating Trial Locations (4 Sites)

Advocate Lutheran General Hospital — Park Ridge, Illinois
Cooper University Health Care — Cherry Hill, New Jersey
Thomas Jefferson University — Philadelphia, Pennsylvania
Aurora St. Luke's Medical Center — Milwaukee, Wisconsin

💰 Cost, Insurance & Patient Rights

100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

🏛️ View Official NIH Record ↗